Cellular therapy intended to treat pain & function associated w/ knee osteoarthritis entering a pivotal/Phase III trial

Biotechnology

GID's headquarters in Louisville, CO, United States

William Cimino

Sandeep Samudre

Frank Dilazzaro

Dale Tomrdle

G. Patrick Maxwell

J. William Futrell

Ramón Llull

Morgan St. John

Adam Katz

John Marous

Nicholas Pachuda

Roy J. Bostock

The Leadership Team at GID is responsible for guiding the strategic direction and operational execution of the company as it prepares for pivotal Phase III trials of its cellular therapy for knee osteoarthritis. Composed of founders and senior vice presidents, this team focuses on overseeing business development, financial management, and operational efficiency to ensure successful trial outcomes and market readiness.

Leadership Team

The Business Development and Regulatory Affairs team at GID is responsible for driving strategic partnerships and collaborations to advance the cellular therapy aimed at alleviating knee osteoarthritis symptoms. They ensure compliance with regulatory requirements, oversee clinical trial readiness, and engage with stakeholders to facilitate smooth progression into pivotal Phase III trials, ultimately aiming to bring innovative treatments to market.

Business Development and Regulatory Affairs

This department provides strategic direction and governance for the organization.

Executive Leadership

This department manages financial planning, budgeting, and operational efficiency to support the organization's overall goals.

Finance and Operations

This department oversees organizational strategy and decision-making.

GID

Org chart

Board & advisors

Teams

Leadership Team

Business Development and Regulatory Affairs

Executive Leadership

Finance and Operations

Leadership Group

Offices

GID

Org chart

Board & advisors

Teams

Leadership Team

Business Development and Regulatory Affairs

Executive Leadership

Finance and Operations

Leadership Group

Offices

Related companies